Analyzing Oak Grove Capital LLC's Q3 and Q4 2022 Holdings: Changes and Implications

Oak Grove Capital LLC is a registered investment adviser with over $360 million in assets under management. As part of their regulatory filings, they submit a quarterly Form 13F that discloses their holdings in publicly traded securities. In this blog post, we will analyze Oak Grove's Q3 and Q4 2022 holdings, based on their most recent filing, and identify changes in holdings and implications for investors.

First, let's take a look at the top holdings of Oak Grove Capital LLC in both quarters. In Q3 2022, Apple Inc. (AAPL) was Oak Grove's top holding with 265,633 shares worth $36,711,000 or 10.2% of their portfolio. This was followed by Advanced Micro Devices Inc. (AMD) with 558,568 shares worth $35,391,000 or 9.8% of their portfolio. In Q4 2022, Brookfield Corp. (BN.TO) emerged as the top holding with 526,868 shares worth $16,575,000 or 4.6% of their portfolio.

Interestingly, no options were exercised in Q3 2022 while a significant number of call and put options were exercised in Q4 2022. For example, Apple Inc. (AAPL) had 76,900 call options exercised worth $2,933,000 and 52,100 put options worth $1,479,000. Similarly, Advanced Micro Devices Inc. (AMD) had 42,500 call options exercised worth $0 and 258,076 put options worth $16,715,000.

There were also some notable reductions in holdings from Q3 to Q4 2022. For example, Oak Grove Capital LLC reduced their holdings in Advanced Micro Devices Inc. (AMD) from 558,568 shares to 258,076 shares, a 52.8% reduction. They also reduced their holdings in Coherent Corp. (COHR) from 333,332 shares to 163,162 shares, a 50.7% reduction. In contrast, Novo Nordisk A/S (NVO) saw a significant increase in holdings from 12,799 shares to 67,020 shares, a 611.4% increase.

Some of the implications of these changes in holdings include potential shifts in sector and industry allocation, potential gains or losses based on certain company events or market conditions, and potential changes in risk exposure. For example, reduced holdings in Advanced Micro Devices Inc. (AMD) may reflect a shift in sector allocation away from semiconductors, while increased holdings in Novo Nordisk A/S (NVO) may reflect a bullish outlook on healthcare.

In summary, Oak Grove Capital LLC's Q3 and Q4 2022 holdings show some interesting changes in holdings and potential implications for investors. By analyzing these changes, investors can gain a more comprehensive understanding of Oak Grove's investment strategy and make better-informed investment decisions.